$441.3
+4.56
(+1.04%)▲
Intuitive Surgical, Inc. is a medical technology company that develops and manufactures robotic-assisted surgical systems and instruments.
1.74%
Downside
Day's Volatility :2.81%
Upside
1.09%
42.25%
Downside
52 Weeks Volatility :45.64%
Upside
5.86%
Period | Intuitive Surgical, Inc. | Sector (Health Care) | Index (NASDAQ Composite) |
---|---|---|---|
3 Months | 16.36% | 6.5% | 7.9% |
6 Months | 16.54% | 7.1% | 11.2% |
1 Year | 32.6% | 9.8% | 21.6% |
3 Years | 35.62% | 14.2% | 15.8% |
Market Capitalization | 161.3B |
Book Value | $41.4 |
Earnings Per Share (EPS) | 5.81 |
PE Ratio | 78.14 |
PEG Ratio | 7.13 |
Wall Street Target Price | 468.85 |
Profit Margin | 27.65% |
Operating Margin TTM | 28.23% |
Return On Assets TTM | 7.99% |
Return On Equity TTM | 15.77% |
Revenue TTM | 7.6B |
Revenue Per Share TTM | 21.45 |
Quarterly Revenue Growth YOY | 14.499999999999998% |
Gross Profit TTM | 4.2B |
EBITDA | 2.4B |
Diluted Eps TTM | 5.81 |
Quarterly Earnings Growth YOY | 0.24 |
EPS Estimate Current Year | 6.63 |
EPS Estimate Next Year | 7.66 |
EPS Estimate Current Quarter | 1.54 |
EPS Estimate Next Quarter | 1.57 |
What analysts predicted
Upside of 6.24%
FY18 | Y/Y Change | |
---|---|---|
Revenue | 3.7B | ↑ 19.03% |
Net Income | 1.1B | ↑ 70.89% |
Net Profit Margin | 30.29% | ↑ 9.2% |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 4.5B | ↑ 20.25% |
Net Income | 1.4B | ↑ 22.29% |
Net Profit Margin | 30.8% | ↑ 0.51% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 4.4B | ↓ 2.68% |
Net Income | 1.1B | ↓ 23.11% |
Net Profit Margin | 24.33% | ↓ 6.47% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 5.7B | ↑ 31.01% |
Net Income | 1.7B | ↑ 60.72% |
Net Profit Margin | 29.85% | ↑ 5.52% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 6.2B | ↑ 8.97% |
Net Income | 1.3B | ↓ 22.43% |
Net Profit Margin | 21.25% | ↓ 8.6% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 7.1B | ↑ 14.49% |
Net Income | 1.8B | ↑ 35.98% |
Net Profit Margin | 25.24% | ↑ 3.99% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 1.7B | ↑ 2.49% |
Net Income | 355.3M | ↑ 9.36% |
Net Profit Margin | 20.95% | ↑ 1.32% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 1.8B | ↑ 3.52% |
Net Income | 420.8M | ↑ 18.44% |
Net Profit Margin | 23.96% | ↑ 3.01% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 1.7B | ↓ 0.69% |
Net Income | 415.7M | ↓ 1.21% |
Net Profit Margin | 23.84% | ↓ 0.12% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 1.9B | ↑ 10.59% |
Net Income | 606.2M | ↑ 45.83% |
Net Profit Margin | 31.44% | ↑ 7.6% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Revenue | 1.9B | ↓ 1.96% |
Net Income | 544.9M | ↓ 10.11% |
Net Profit Margin | 28.82% | ↓ 2.62% |
Q2 FY24 | Q/Q Change | |
---|---|---|
Revenue | 2.0B | ↑ 6.31% |
Net Income | 526.9M | ↓ 3.3% |
Net Profit Margin | 26.22% | ↓ 2.6% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 7.8B | ↑ 36.27% |
Total Liabilities | 1.2B | ↑ 12.41% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 9.7B | ↑ 24.04% |
Total Liabilities | 1.4B | ↑ 24.96% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 11.2B | ↑ 14.75% |
Total Liabilities | 1.4B | ↓ 2.67% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 13.6B | ↑ 21.36% |
Total Liabilities | 1.6B | ↑ 13.74% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 13.0B | ↓ 4.29% |
Total Liabilities | 1.9B | ↑ 16.08% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 15.4B | ↑ 19.02% |
Total Liabilities | 2.0B | ↑ 9.82% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 13.1B | ↑ 0.61% |
Total Liabilities | 1.8B | ↓ 5.5% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 13.9B | ↑ 6.51% |
Total Liabilities | 1.9B | ↑ 10.49% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 14.7B | ↑ 5.82% |
Total Liabilities | 2.1B | ↑ 7.49% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 15.4B | ↑ 4.95% |
Total Liabilities | 2.0B | ↓ 2.15% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 15.8B | ↑ 2.5% |
Total Liabilities | 1.8B | ↓ 12.85% |
Q2 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 16.6B | ↑ 5.19% |
Total Liabilities | 1.9B | ↑ 4.03% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 1.2B | ↑ 2.25% |
Investing Cash Flow | -1.0B | ↓ 377.16% |
Financing Cash Flow | 126.3M | ↓ 106.6% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 1.6B | ↑ 36.65% |
Investing Cash Flow | -1.2B | ↑ 9.98% |
Financing Cash Flow | -168.4M | ↓ 233.33% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 1.5B | ↓ 7.1% |
Investing Cash Flow | -940.6M | ↓ 18.52% |
Financing Cash Flow | -85.7M | ↓ 49.11% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 2.1B | ↑ 40.72% |
Investing Cash Flow | -2.5B | ↑ 161.69% |
Financing Cash Flow | 43.0M | ↓ 150.18% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 1.5B | ↓ 28.65% |
Investing Cash Flow | 1.4B | ↓ 155.69% |
Financing Cash Flow | -2.6B | ↓ 6082.09% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 371.4M | ↓ 15.19% |
Investing Cash Flow | 573.1M | ↓ 0.3% |
Financing Cash Flow | -381.2M | ↓ 60.44% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 665.7M | ↑ 79.24% |
Investing Cash Flow | 557.6M | ↓ 2.7% |
Financing Cash Flow | 63.3M | ↓ 116.61% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 548.4M | ↓ 17.62% |
Investing Cash Flow | -446.6M | ↓ 180.09% |
Financing Cash Flow | 61.8M | ↓ 2.37% |
Sell
Neutral
Buy
Intuitive Surgical, Inc. is currently in a neutral trading position according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
![]() Intuitive Surgical, Inc. | -1.32% | 16.54% | 32.6% | 35.62% | 148.32% |
![]() Resmed Inc. | 11.69% | 9.57% | -6.0% | -19.79% | 64.22% |
![]() Becton, Dickinson And Company | 0.5% | -1.64% | -17.69% | -6.68% | -8.49% |
![]() West Pharmaceutical Services Inc | -14.37% | -23.3% | -26.95% | -26.58% | 102.44% |
![]() Alcon Ag | 2.41% | 20.84% | 8.21% | 30.7% | 54.72% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
![]() Intuitive Surgical, Inc. | 78.14 | 78.14 | 7.13 | 6.63 | 0.16 | 0.08 | NA | 41.4 |
![]() Resmed Inc. | 32.24 | 32.24 | 1.75 | 7.73 | 0.22 | 0.12 | 0.01 | 31.52 |
![]() Becton, Dickinson And Company | 50.71 | 50.71 | 1.34 | 13.04 | 0.05 | 0.03 | 0.02 | 88.74 |
![]() West Pharmaceutical Services Inc | 42.71 | 42.71 | 6.72 | 7.74 | 0.21 | 0.11 | 0.0 | 36.72 |
![]() Alcon Ag | 44.05 | 44.05 | 4.59 | 3.07 | 0.05 | 0.02 | 0.0 | 42.13 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
![]() Intuitive Surgical, Inc. | Buy | $161.3B | 148.32% | 78.14 | 27.65% |
![]() Resmed Inc. | Buy | $30.8B | 64.22% | 32.24 | 20.91% |
![]() Becton, Dickinson And Company | Buy | $68.6B | -8.49% | 50.71 | 6.76% |
![]() West Pharmaceutical Services Inc | Buy | $23.7B | 102.44% | 42.71 | 19.42% |
![]() Alcon Ag | Buy | $45.8B | 54.72% | 44.05 | 10.96% |
Insights on Intuitive Surgical, Inc.
Revenue is up for the last 2 quarters, 1.89B → 2.00B (in $), with an average increase of 5.9% per quarter
Netprofit is down for the last 3 quarters, 606.2M → 526.9M (in $), with an average decrease of 6.7% per quarter
Vanguard Group Inc
BlackRock Inc
T. Rowe Price Associates, Inc.
State Street Corporation
FMR Inc
Capital World Investors
Intuitive Surgical, Inc. is an American corporation that develops, manufactures, and markets robotic products designed to improve clinical outcomes of patients through minimally invasive surgery, most notably with the da Vinci Surgical System. The company is part of the NASDAQ-100 and S&P 500.
Organization | Intuitive Surgical, Inc. |
Employees | 13676 |
CEO | Dr. Gary S. Guthart Ph.D. |
Industry | Health Technology |